- MD – Queen’s
- FRCPC – Western
- Fellowship – Western
- Canadian Psychiatric Association
- Ontario Psychiatric Association
- American Academy of Sleep Medicine
- Canadian Sleep Society
- Canadian Medical Association
- Ontario Medical Association
Prior to transitioning to CAMH, Michael Mak was an Assistant Professor in the Department of Psychiatry and Internal Medicine (cross-appointed) at Western University in London, Ontario. At UWO, he was heavily involved in both undergraduate and postgraduate education. He received his MD from Queen’s University in Kingston, and subsequently completed his Psychiatry residency and fellowship in Sleep Medicine at Western University. He worked in the Consultation-Liaison Psychiatry service and Sleep Medicine Clinic at London Health Sciences Centre. He established a psychiatric clinic focusing on patients with comorbid COPD, Cystic Fibrosis and other pulmonary diseases in London. He taught the Journal Club for the postgraduate Psychiatry program and was the Wellness Lead. His research interests include: quality improvement and epidemiology in medical psychiatry; management of insomnia; psychiatric manifestations of sleep disorders; and novel usage of technology in the management of psychiatric and medical disorders. He has most recently published a book chapter on Inflammation and Depression in Patients with Autoimmune Disease, Diabetes, and Obesity.
Dr. Mak’s research interests include: quality improvement and epidemiology in medical psychiatry; management of insomnia; psychiatric manifestations of sleep disorders; and novel usage of technology in the management of psychiatric and medical disorders.
Book Chapter: Gregory JM, Mak M, McIntyre RS. Inflammation and Depression in Patients with Autoimmune Disease, Diabetes, and Obesity. Bernhard Baune (Ed.), Inflammation and Immunity in Depression. Elsevier. (May 2018)
Peer Reviewed Publication: Pallaveshi L, Mak M, Rudnick A. Predictors of Clozapine Funding in Southwestern Ontario. Psychiatr Serv. 2016;67(1):143-4.
AppointmentsAssistant Professor, Department of Psychiatry, University of Toronto
2017 – 2019 Primary Investigator: Tryptophan as treatment for Insomnia in the Intellectual Disability and Autism Spectrum Disorder Populations. PI: Mak M. Collaborators: Chitpin J, Kwiatkowski D, Nicolson R. 3500 CAD.
2016 – 2019 Co-Primary Investigator: Chronic Disease Management Initiative. PIs: Links PS, Mak M. Collaborators: Calvin J, Wetmore S, Eynan R, Licskai C, Valiquet S, Sibbald S. 166000 CAD.
2016 – 2019 Primary Investigator: Diagnostic Accuracy in an Academic Consultation-Liaison Service. PI: Mak M. Collaborators: Charbonneau J, King R, Ulch S, Maclean M, Barr J, Garcia C. 7500 CAD.